BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28300834)

  • 1. Heterodimers of photoreceptor-specific nuclear receptor (PNR/NR2E3) and peroxisome proliferator-activated receptor-γ (PPARγ) are disrupted by retinal disease-associated mutations.
    Fulton J; Mazumder B; Whitchurch JB; Monteiro CJ; Collins HM; Chan CM; Clemente MP; Hernandez-Quiles M; Stewart EA; Amoaku WM; Moran PM; Mongan NP; Persson JL; Ali S; Heery DM
    Cell Death Dis; 2017 Mar; 8(3):e2677. PubMed ID: 28300834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterodimer formation with retinoic acid receptor RXRα modulates coactivator recruitment by peroxisome proliferator-activated receptor PPARγ.
    Kilu W; Merk D; Steinhilber D; Proschak E; Heering J
    J Biol Chem; 2021 Jul; 297(1):100814. PubMed ID: 34081964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid hormone receptor beta mutants: Dominant negative regulators of peroxisome proliferator-activated receptor gamma action.
    Araki O; Ying H; Furuya F; Zhu X; Cheng SY
    Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16251-6. PubMed ID: 16260719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive analysis of sequence variants and putative disease-causing mutations in photoreceptor-specific nuclear receptor NR2E3.
    Kanda A; Swaroop A
    Mol Vis; 2009 Oct; 15():2174-84. PubMed ID: 19898638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential dimerization of variants linked to enhanced S-cone sensitivity syndrome (ESCS) located in the NR2E3 ligand-binding domain.
    von Alpen D; Tran HV; Guex N; Venturini G; Munier FL; Schorderet DF; Haider NB; Escher P
    Hum Mutat; 2015 Jun; 36(6):599-610. PubMed ID: 25703721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The crystal structure of the orphan nuclear receptor NR2E3/PNR ligand binding domain reveals a dimeric auto-repressed conformation.
    Tan MH; Zhou XE; Soon FF; Li X; Li J; Yong EL; Melcher K; Xu HE
    PLoS One; 2013; 8(9):e74359. PubMed ID: 24069298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The optimal corepressor function of nuclear receptor corepressor (NCoR) for peroxisome proliferator-activated receptor γ requires G protein pathway suppressor 2.
    Guo C; Li Y; Gow CH; Wong M; Zha J; Yan C; Liu H; Wang Y; Burris TP; Zhang J
    J Biol Chem; 2015 Feb; 290(6):3666-79. PubMed ID: 25519902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A signature motif mediating selective interactions of BCL11A with the NR2E/F subfamily of orphan nuclear receptors.
    Chan CM; Fulton J; Montiel-Duarte C; Collins HM; Bharti N; Wadelin FR; Moran PM; Mongan NP; Heery DM
    Nucleic Acids Res; 2013 Nov; 41(21):9663-79. PubMed ID: 23975195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-764406 is a partial agonist of human peroxisome proliferator-activated receptor gamma. The role of Cys313 in ligand binding.
    Elbrecht A; Chen Y; Adams A; Berger J; Griffin P; Klatt T; Zhang B; Menke J; Zhou G; Smith RG; Moller DE
    J Biol Chem; 1999 Mar; 274(12):7913-22. PubMed ID: 10075686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the DNA-binding domain of NR2E3 affect in vivo dimerization and interaction with CRX.
    Roduit R; Escher P; Schorderet DF
    PLoS One; 2009 Oct; 4(10):e7379. PubMed ID: 19823680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct functions of photoreceptor cell-specific nuclear receptor, thyroid hormone receptor beta2 and CRX in one photoreceptor development.
    Yanagi Y; Takezawa S; Kato S
    Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3489-94. PubMed ID: 12407160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimers: intermolecular synergy requires only the PPARgamma hormone-dependent activation function.
    Schulman IG; Shao G; Heyman RA
    Mol Cell Biol; 1998 Jun; 18(6):3483-94. PubMed ID: 9584188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The orphan nuclear receptor Rev-Erbalpha is a peroxisome proliferator-activated receptor (PPAR) gamma target gene and promotes PPARgamma-induced adipocyte differentiation.
    Fontaine C; Dubois G; Duguay Y; Helledie T; Vu-Dac N; Gervois P; Soncin F; Mandrup S; Fruchart JC; Fruchart-Najib J; Staels B
    J Biol Chem; 2003 Sep; 278(39):37672-80. PubMed ID: 12821652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to thyroid hormone, and peroxisome-proliferator-activated receptor gamma resistance.
    Chatterjee VK
    Biochem Soc Trans; 2001 May; 29(Pt 2):227-31. PubMed ID: 11356159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired peroxisome proliferator-activated receptor gamma function through mutation of a conserved salt bridge (R425C) in familial partial lipodystrophy.
    Jeninga EH; van Beekum O; van Dijk AD; Hamers N; Hendriks-Stegeman BI; Bonvin AM; Berger R; Kalkhoven E
    Mol Endocrinol; 2007 May; 21(5):1049-65. PubMed ID: 17312272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Basis for Anti-non-alcoholic Fatty Liver Disease and Diabetic Dyslipidemia Drug Saroglitazar as a PPAR α/γ Dual Agonist.
    Honda A; Kamata S; Satta C; Machida Y; Uchii K; Terasawa K; Nemoto A; Oyama T; Ishii I
    Biol Pharm Bull; 2021; 44(9):1210-1219. PubMed ID: 34471049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor.
    Koppen A; Houtman R; Pijnenburg D; Jeninga EH; Ruijtenbeek R; Kalkhoven E
    Mol Cell Proteomics; 2009 Oct; 8(10):2212-26. PubMed ID: 19596656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural determinants of the agonist-independent association of human peroxisome proliferator-activated receptors with coactivators.
    Molnár F; Matilainen M; Carlberg C
    J Biol Chem; 2005 Jul; 280(28):26543-56. PubMed ID: 15888456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orphan nuclear receptor PNR/NR2E3 stimulates p53 functions by enhancing p53 acetylation.
    Wen Z; Pyeon D; Wang Y; Lambert P; Xu W; Ahlquist P
    Mol Cell Biol; 2012 Jan; 32(1):26-35. PubMed ID: 22025681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system.
    Auclair M; Vigouroux C; Boccara F; Capel E; Vigeral C; Guerci B; Lascols O; Capeau J; Caron-Debarle M
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):829-38. PubMed ID: 23393388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.